Loncastuximab Tesirine in Combination With Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma
Clinical trial NCT04998669 · RECRUITING
Trial details
- NCT number
- NCT04998669
- Sponsor
- Juan P. Alderuccio, MD
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-11
- Primary completion
- 2027-08-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.